Target intelligence / Profile preview

Actinidain

Molecular classification
Enzyme, Cysteine protease, Peptidase C1 family
01

Overview

Actinidain, also commonly referred to as actinidin, is a cysteine protease enzyme (EC 3.4.22.14) highly abundant in kiwifruit (genus Actinidia), and to a lesser extent present in some other fruits such as pineapple, mango, banana, fig, and papaya. It belongs to the peptidase C1 family (papain-like proteases) and is closely related to enzymes like papain and bromelain, sharing strong similarities in size, structure, and catalytic mechanism. Actinidain is responsible for a substantial portion of the proteolytic activity in kiwifruit, constituting up to 40–50% of the soluble protein content in green (Hayward) kiwifruit at harvest. It exhibits a broad substrate specificity, hydrolyzing a wide range of peptide bonds unattainable by other digestive proteases such as pepsin, and can enhance the digestion of animal and plant proteins in the human gastrointestinal tract. This property underlies its commercial use as a meat tenderizer and as a coagulating agent in dairy product manufacturing. Biochemically, actinidain is active over a wide pH range (pH 3–10; optimum ~pH 5–7), has an optimum temperature around 40°C, and denatures at 60°C—lower than related enzymes like bromelain and papain. The enzyme has been shown to improve the rate and extent of dietary protein breakdown both in vitro and in vivo, suggesting potential as a digestive aid, especially for individuals with reduced digestive efficiency such as the elderly. However, actinidain is also a significant allergen and is the major cause of kiwifruit allergy (allergen listed as Act d 1). Allergic reactions to kiwifruit (mediated by actinidain) can range from mild oral irritation to severe anaphylactic responses. No therapeutic drugs are currently known to specifically target actinidain, and it is not considered a therapeutic target in the sense of a druggable receptor, enzyme, or transporter relevant to disease treatment. Additional notes: - Actinidain is not a human therapeutic target and is not involved in major disease pathways apart from its allergenic potential. - It is often studied as a model enzyme for structure-function analysis among cysteine proteases and as a food ingredient for protein digestion studies. In summary, actinidain is a plant cysteine protease involved in dietary protein digestion and food processing, with significance as a food allergen, but it is not considered a canonical therapeutic drug target.

Other names
ActinidinActinidia anionic proteaseproteinase A2 of Actinidia chinensisAct d 1
02

Mechanism of action

Proteolytic cleavage of peptide bonds (hydrolyzes proteins, particularly at the carboxyl side of lysine residues)

03

Biological functions

Protein digestionHydrolysis of peptide bondsFood protein breakdownAllergen (in kiwifruit)
04

Disease associations

Allergy (Actinidain is a known allergen in kiwifruit)
05

Safety considerations

Allergenicity (can trigger allergic reactions in sensitive individuals)
06

Biomarkers

Act d 1 (for kiwifruit allergy diagnosis)

Beyond the preview

Go deeper on Actinidain.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actinidain.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call